GlassScriptPhysician profile
Xibei Jia
NPI 1982024303
$1,464.33
in general payments reported to CMS, 2019-2025
22 companies · $485 in 2025
The $485 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2021: $38.07 · 2022: $281 · 2023: $264 · 2024: $287 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $248.21 | 2024-2025 | Upsylon, Axonics |
| Abbvie INC. | $174.23 | 2019-2025 | |
| 180 Medical, INC. | $132.38 | 2022-2024 | Cure Catheter, Gentlecath, Gentlecath Glide |
| Urovant Sciences INC | $90.24 | 2022 | |
| Dentsply Ih Ab | $85.40 | 2025 | Lofric |
| Sumitomo Pharma America, INC. | $79.91 | 2023-2025 | Gemtesa, Orgovyx |
| Tolmar, INC. | $75.10 | 2024-2025 | Eligard, Jatenzo |
| Medtronic, INC. | $67.90 | 2023 | Interstim |
| Astellas Pharma US INC | $64.82 | 2022-2024 | Myrbetriq |
| Laborie Medical Technologies Corp. | $53.78 | 2023 | |
| Accord Healthcare, INC. | $51.42 | 2024 | |
| Urogen Pharma, INC. | $49.26 | 2025 | |
| Abc Home Medical Supply, INC. | $48.05 | 2025 | |
| Pfizer INC. | $46.46 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $41.43 | 2025 | Provenge |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $37.26 | 2022 | |
| Convatec INC. | $24.79 | 2022 | |
| Becton, Dickinson and Company | $22.35 | 2025 | Bard X-Force Balloon Dilation Catheter |
| Acerus Pharmaceuticals Corporation | $21.84 | 2021 | |
| Alnylam Pharmaceuticals INC. | $20.65 | 2022 | |
| Axonics, INC. | $14.89 | 2023 | Axonics |
| Antares Pharma, INC. | $13.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xibei Jia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.